Risk Prediction Model for Iodinated Contrast Medium Extravasation
Development and Validation of a Risk Prediction Model for Iodinated Contrast Medium Extravasation in Patients Undergoing Contrast-enhanced Computed Tomography
Zhang Wenyan
1,000 participants
Jan 25, 2025
OBSERVATIONAL
Conditions
Summary
This study aims to develop a risk prediction model for iodine contrast agent extravasation from peripheral veins and to implement this model clinically to establish a risk control management system for iodine contrast agent extravasation.A case-control study design was employed to collect data for model development. The case group comprised patients who experienced iodine contrast agent extravasation during enhanced CT examinations, while the control group included patients who underwent similar examinations without extravasation.
Eligibility
Inclusion Criteria2
- Volunteer to participate in this study.
- Without contraindications such as iodine contrast allergy or hyperthyroidism. -
Exclusion Criteria2
- There are communication barriers between researchers and patients.
- Due to critical condition or unstable vital signs, patients should be transferred to relevant clinical departments for treatment or observation immediately after examination.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06859242